The trademark application SUPRAME was filed by Immatics Biotechnologies GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). Application under examination.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 42 with Conducting of medical, scientific and clinical studies in the field of engineered T-cell receptor-based immunotherapy against solid cancer and conducting clinical trials and analyses in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding information..